These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The significance of the concept of obsessive-compulsive spectrum disorder to the treatment of chronic nonmalignant pain. Bienvenu OJ, Cannistraro PA. Curr Pain Headache Rep; 2002 Feb; 6(1):40-3. PubMed ID: 11749876 [Abstract] [Full Text] [Related]
47. Anger management style and emotional reactivity to noxious stimuli among chronic pain patients and healthy controls: the role of endogenous opioids. Bruehl S, Burns JW, Chung OY, Quartana P. Health Psychol; 2008 Mar 01; 27(2):204-14. PubMed ID: 18377139 [Abstract] [Full Text] [Related]
50. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR. Biol Psychiatry; 1995 Aug 01; 38(3):138-49. PubMed ID: 7578657 [Abstract] [Full Text] [Related]
51. Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism. Mangold DL, Peyrot M, Giggey P, Wand GS. Neuropsychopharmacology; 2000 Jun 01; 22(6):595-607. PubMed ID: 10788759 [Abstract] [Full Text] [Related]
52. Anger management style and emotional reactivity to noxious stimuli among chronic pain patients and healthy controls: the role of endogenous opioids. Bruehl S, Burns JW, Chung OY, Quartana P. Health Psychol; 2008 Mar 01; 27(2):204-14. PubMed ID: 18377139 [Abstract] [Full Text] [Related]
53. The Maudsley Obsessive-Compulsive Stimuli Set: validation of a standardized paradigm for symptom-specific provocation in obsessive-compulsive disorder. Mataix-Cols D, Lawrence NS, Wooderson S, Speckens A, Phillips ML. Psychiatry Res; 2009 Aug 15; 168(3):238-41. PubMed ID: 19515429 [Abstract] [Full Text] [Related]